Literature DB >> 18729851

Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia.

Florent M Martin, Josef Prchal, Jorge Nieva, Alan Saven, Jeffrey Andrey, Kelly Bethel, James C Barton, Gow Aripally, Sylvia S Bottomley, Jeffrey S Friedman.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18729851      PMCID： PMC2603068          DOI： 10.1111/j.1365-2141.2008.07358.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes.

Authors:  N Gattermann
Journal:  Leuk Res       Date:  2000-02       Impact factor: 3.156

2.  Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy.

Authors:  A Rötig; V Cormier; S Blanche; J P Bonnefont; F Ledeist; N Romero; J Schmitz; P Rustin; A Fischer; J M Saudubray
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

3.  Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes.

Authors:  Poluru L Reddy; Vilasini T Shetty; Diya Dutt; Aaron York; Saleem Dar; Suneel D Mundle; Krishnan Allampallam; Sairah Alvi; Naomi Galili; Gurveen Sethi Saberwal; Shalini Anthwal; Malihi Shaikh; Samia Suleman; Shaista Y Kamal; Azra Raza
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

4.  A method for rapid mouse siderocyte enrichment.

Authors:  Florent M Martin; Gabriela Bydlon; Megan L Welsh; Jeffrey S Friedman
Journal:  Exp Hematol       Date:  2005-12       Impact factor: 3.084

5.  Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A).

Authors:  R Allikmets; W H Raskind; A Hutchinson; N D Schueck; M Dean; D M Koeller
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

6.  Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA).

Authors:  Yelena Bykhovskaya; Kari Casas; Emebet Mengesha; Aida Inbal; Nathan Fischel-Ghodsian
Journal:  Am J Hum Genet       Date:  2004-04-22       Impact factor: 11.025

7.  Mitochondrial DNA mutations in patients with myelodysplastic syndromes.

Authors:  Myung Geun Shin; Sachiko Kajigaya; Barbara C Levin; Neal S Young
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

8.  X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley.

Authors:  P D Cotter; D L Rucknagel; D F Bishop
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

9.  Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.

Authors:  Michael Wulfert; Anna C Küpper; Christoph Tapprich; Sylvia S Bottomley; David Bowen; Ulrich Germing; Rainer Haas; Norbert Gattermann
Journal:  Exp Hematol       Date:  2008-05       Impact factor: 3.084

10.  The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload.

Authors:  Clara Camaschella; Alessandro Campanella; Luigia De Falco; Loredana Boschetto; Roberta Merlini; Laura Silvestri; Sonia Levi; Achille Iolascon
Journal:  Blood       Date:  2007-05-07       Impact factor: 22.113
  10 in total
  2 in total

1.  SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation.

Authors:  Joy G Mohanty; Enika Nagababu; Jeffrey S Friedman; Joseph M Rifkind
Journal:  Exp Hematol       Date:  2012-11-06       Impact factor: 3.084

2.  SOD2 deficient erythroid cells up-regulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism.

Authors:  Florent M Martin; Xiuling Xu; Katharina von Löhneysen; Timothy J Gilmartin; Jeffrey S Friedman
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.